Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1Breast 1

Conditions

Melanoma 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Nivolumab 7Ipilimumab 4pembrolizumab 3Interferon alpha-2 3relatlimab 2Drug Therapy 2Dacarbazine 2sargramostim 1salicylhydroxamic acid 1peginterferon alfa-2b 1peginterferon alfa-2a 1molgramostim 1entrectinib 1cyclopropapyrroloindole 1cobimetinib 1atezolizumab 1Vemurafenib 1Triamcinolone Acetonide 1Temozolomide 1Specimen Handling 1Sonazoid 1Ranibizumab 1Propranolol 1Lenalidomide 1Introns 1Immunotherapy 1Imiquimod 1Fatty Acids, Omega-3 1Crizotinib 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Melanoma × Sonazoid × Clear all
NCT07310758 2025-12-30

Contrast-enhanced Ultrasound for Sentinel Node Detection

The Netherlands Cancer Institute

Phase 2/3 Recruiting
91 enrolled
BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡